SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-002614
Filing Date
2021-05-20
Accepted
2021-05-20 16:10:50
Documents
1
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 form4-05202021_040537.html 4  
1 form4-05202021_040537.xml 4 4438
  Complete submission text file 0001415889-21-002614.txt   6084
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 21944578